GILD Stock: Gilead Sciences, Inc. Stock Price, Analysis & Insights
Get live GILD stock price $134.36, comprehensive Gilead Sciences, Inc. stock analysis, charts, news, and expert forecast. Real-time GILD stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truv...
Company Information
- CEO
- Daniel O'Day
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 17600
Contact Information
- Website
- https://www.gilead.com
- Address
- 333 Lakeside Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 166.8 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.1)
✓ Lower volatility stock (Beta: 0.33) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Gilead Sciences, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Gilead Sciences, Inc.
- ⚠Investors should consider how Gilead Sciences, Inc. fits within their overall portfolio allocation
Market Cap
166.82B
P/E Ratio (TTM)
16.05
Beta
0.33
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Healthcare Stocks
Compare GILD with:
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.